Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

No neurodevelopmental benefit of cerebral oximetry in the first randomised trial in preterm infants during the first days of life (SafeBoosC II)

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. The impact of the COVID pandemic on prematurity rates: Conflicting results, publication ethics and academic frustration

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Nationwide study found higher paediatric readiness in emergency departments and trauma centres with a paediatrician on-site

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The mortality of immature infants, who decides?

    Research output: Contribution to journalEditorialResearchpeer-review

  4. Brain tumours in children and adolescents may affect the circadian rhythm and quality of life

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. The impact of the COVID pandemic on prematurity rates: Conflicting results, publication ethics and academic frustration

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The mortality of immature infants, who decides?

    Research output: Contribution to journalEditorialResearchpeer-review

View graph of relations

AIM: Cerebral hypoxia has been associated with neurodevelopmental impairment. We studied whether reducing cerebral hypoxia in extremely preterm infants during the first 72 hours of life affected neurological outcomes at two years of corrected age.

METHODS: In 2012-2013 the phase II randomised Safeguarding the Brains of our Smallest Children trial compared visible cerebral near infrared spectroscopy (NIRS) monitoring in an intervention group and blinded NIRS monitoring in a control group. Cerebral hypoxia was significantly reduced in the intervention group. We followed up 115 survivors from eight European centres at two years of corrected age, by conducting a medical examination and assessing their neurodevelopment with the Bayley Scales of Infant and Toddler Development, Second or Third Edition and the parental Ages and Stages Questionnaire, (ASQ).

RESULTS: There were no respective differences between the intervention (n=65) and control (n=50) groups with regard to the mean mental developmental index (89.6 ±19.5 versus 88.4 ±14.7, p=0.77), ASQ score (215 ±58 versus 213 ±58, p=0.88) and the number of children with moderate-to-severe neurodevelopmental impairment (10 versus six, p=0.58).

CONCLUSIONS: Cerebral NIRS monitoring was not associated with long-term benefits or harm with regard to neurodevelopmental outcome at two years of corrected age. This article is protected by copyright. All rights reserved.

Original languageEnglish
JournalActa paediatrica
Volume108
Issue number2
Pages (from-to)275-281
Number of pages7
ISSN1651-2227
DOIs
Publication statusPublished - 2019

Bibliographical note

©2018 The Authors. Acta Paediatrica published by John Wiley & Sons Ltd on behalf of Foundation Acta Paediatrica.

    Research areas

  • Ages and stages questionnaire, Bayley scales of infant and toddler development, Cerebral near-infrared spectroscopy, Extremely preterm infants, Neurodevelopment

ID: 54639653